International trade · 08/05/2025

BioMarin Pharmaceutical Inc. Files Complaint with U.S. International Trade Commission Over Certain Drug Products

BioMarin Pharmaceutical Inc. has filed a complaint with the U.S. International Trade Commission alleging violations of the Tariff Act of 1930 due to infringement of a U.S. Reissue Patent No. RE'267, related to certain drug products containing C-type natriuretic peptide variants.